
The discovery of the unique role of the zzso zzso of nuclear factor zzso zzso zzso zzso signaling zzso in the process of zzso has led to the targeting of this zzso as a novel therapeutic approach in the management of zzso In a phase II clinical trial, a single subcutaneous administration of zzso a zzso zzso fully human zzso zzso to zzso led to a profound and prolonged zzso of bone zzso which was associated with significant increases in bone mineral density in zzso zzso The zzso zzso and skeletal and zzso safety issues of zzso are being addressed in ongoing phase III clinical zzso The potential of zzso as a therapeutic target in the treatment of osteoporosis is discussed in this zzso 

